Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ginkgo Bioworks Holdings, Inc. WT

Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Stock Overview

Explore Ginkgo Bioworks Holdings, Inc. WT’s financial performance, market position, analyst ratings, and future outlook.

DNA-WT●NYSE
HealthcareBiotechnology
$0.27
$0.008(2.76%)
U.S. Market is Open · 14:19

Ginkgo Bioworks Holdings, Inc. WT (DNA-WT)

Meyka AI Score

Z

Key Financials

Market Cap18.7B
P/E Ratio-1.74
EPS (TTM)N/A
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.32

DNA-WT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Ginkgo Bioworks Holdings, Inc. WT (NYSE: DNA-WT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Ginkgo Bioworks Holdings, Inc. WT's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DNA-WT on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.32 for the NYSE listing.

Key metrics behind Ginkgo Bioworks Holdings, Inc. WT's NYSE-traded stock include a P/E ratio of -1.74 and a market capitalization of 18.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of DNA-WT on the NYSE.

Price Performance (NYSE: DNA-WT)

1-Day Change
N/A
5-Day Change
20.39%
1-Month Change
-9.03%
3-Month Change
33.79%
6-Month Change
103.18%
Year-to-Date (YTD) Change
33.79%
1-Year Change
301.76%
3-Year Change
-57.62%
5-Year Change
-57.62%
All-Time (Max) Change
-57.62%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

CountryNaN

Frequently Asked Questions